VanEck Associates
ARCT icon

VanEck Associates’s Arcturus Therapeutics ARCT Stock Holding History

VanEck Associates’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-766
Closed -$93K – 702
2014
Q2 		$93K Buy
766
+154
+25% +$18.6K ﹤0.01% 682
2014
Q1 		$78K Buy
612
+127
+26% +$18.8K ﹤0.01% 665
2013
Q4 		$61K Buy
+485
New +$60.9K ﹤0.01% 658

Other funds holding ARCT

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
AWMDMG
Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return
GL
GLG LLC New York $1.3B AUM 24.01% 1-Year Est. Return
SC
Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $4.2B AUM 21.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $10.3B AUM 30.69% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return